Glytone Acne Bpo Treatment Gel
NDC Package 84262-030-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Glytone Acne Bpo Treatment Gel (benzoyl peroxide gel) gel is a medication used to treat mild to moderate acne. This formulation utilizes a gel delivery system. Marketed by Glytone, Llc, this product is identified by NDC 84262-030 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
84262-030-01
Package Description
60 g in 1 TUBE
Product Code
11-Digit Billing Format
84262003001
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Glytone Acne Bpo Treatment Gel
Non-Proprietary Name
Benzoyl Peroxide Gel
Substance Name
Benzoyl Peroxide
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Regulatory & Marketing

Labeler Name
Glytone, Llc
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-02-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84262-030-01 identifies a specific commercial package of 60 g in 1 tube of Glytone Acne Bpo Treatment Gel, a human over the counter drug labeled by Glytone, Llc. This gel is formulated for topical use and contains benzoyl peroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glytone, Llc on April 02, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat mild to moderate acne. It may be used in combination with other acne treatments. When applied to the skin, benzoyl peroxide works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

How is this Glytone, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84262003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84262-030-01
11-Digit CMS (5-4-2)
84262-0030-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.